Document is current
Any future updates will be listed below
-
Authors
Higashino, Takuya https://orcid.org/0000-0002-8153-1836
Wakabayashi, Masashi
Zenda, Sadamoto
Yasunaga, Yoshichika
Araki, Jun
Mukaigawa, Takashi
Onitsuka, Tetsuro
Nakagawa, Masahiro
Hamahata, Atsumori
Narita, Keigo
Arikawa, Masaki
Takanari, Keisuke
Kadota, Hideki
Yanagisawa, Daisuke
Tanaka, Kentaro
Matsumoto, Hiroshi
Kimata, Yoshihiro
Miyamoto, Shimpei
Sakuraba, Minoru
Kawai, Kenichiro
Terao, Yasunobu
Hyodo, Ikuo
Ishida, Katsuhiro
Yoshimura, Kotaro
-
Funding
Funding for this research was provided by:
Japan Cancer Society
- License Information
-
More Information
Article History
Received: 16 September 2024
Accepted: 23 December 2024
First Online: 30 December 2024
Declarations
:
: In accordance with the Declaration of Helsinki, the study protocol was approved by the National Cancer Center Institutional Review Board (2022–214) on October 24, 2022, prior to the first inclusion in National Cancer Center Hospital East on November 14, 2022, and subsequently approved by all participating institutions. Ethical approval was obtained from institutional ethics boards before patient recruitment.
: Informed consent was obtained from all individual participants included in the study.
: The authors declare no competing interests.
